HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Denis Deffieux Selected Research

vescalagin

11/2018Anti-osteoclastic effects of C-glucosidic ellagitannins mediated by actin perturbation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Denis Deffieux Research Topics

Disease

1B-Cell Lymphoma (Lymphoma, B Cell)
03/2021
1Diabetes Mellitus
05/2020
1Hyperglycemia
05/2020
1Cognitive Dysfunction
01/2020
1Alcoholism (Alcohol Abuse)
01/2020
1Hypoxia (Hypoxemia)
01/2020
1Ischemia
01/2020
1Osteoporosis
11/2018
1Alzheimer Disease (Alzheimer's Disease)
07/2015
1Neoplasms (Cancer)
07/2012

Drug/Important Bio-Agent (IBA)

2PolyphenolsIBA
01/2020 - 07/2015
1Bovine Serum AlbuminIBA
03/2021
1FlavonoidsIBA
03/2021
1Proteins (Proteins, Gene)FDA Link
03/2021
1leucoanthocyanidin dioxygenaseIBA
03/2021
1DNA (Deoxyribonucleic Acid)IBA
03/2021
1LigandsIBA
03/2021
1GlucosidasesIBA
05/2020
1AmylasesFDA Link
05/2020
1StilbenesIBA
01/2020
1vescalaginIBA
11/2018
1Amyloid (Amyloid Fibrils)IBA
07/2015
1Etoposide (VP 16)FDA LinkGeneric
07/2012